Triste, Sherlyn B.
HRN: 04-46-44 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/05/2025
MUPIROCIN 2%, 15G (TUBE)
07/05/2025
07/12/2025
TOPICAL
15g
BID
Decubitus Ulcer
Waiting Final Action
Indication: Prophylaxis Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes